Thomas F. Wierzba

Medicine · Health Sciences

39h-index4.6kcitations90works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(39), Vibrio bacteria research studies(38), Escherichia coli research studies(26), Salmonella and Campylobacter epidemiology(19), Vaccine Coverage and Hesitancy(16)

Publications90 total

Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United States
PLoS ONE·2024Open Access
A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions
Microorganisms·2023· 5 citedOpen Access
The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin
Microorganisms·2023· 4 citedOpen Access
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
Vaccine X·2022· 10 citedOpen Access
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
The Lancet Infectious Diseases·2019· 102 citedOpen Access
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
The Lancet Global Health·2019· 49 citedOpen Access
Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
Vaccine X·2019· 9 citedOpen Access
Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase–associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa
Clinical Infectious Diseases·2019· 23 citedOpen Access
Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference
Vaccine·2019· 31 citedOpen Access
Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
Vaccine X·2019· 39 citedOpen Access
Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
The Lancet Global Health·2019· 157 citedOpen Access
Heterogeneity in ETEC and <i>Shigella </i>Infections: A Subnational Approach Quantifying Risk, Mortality, Morbidity, and Stunting in 11 African Countries
SSRN Electronic Journal·2019Open Access
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Vaccine·2018· 61 citedOpen Access
Oral cholera vaccines and their impact on the global burden of disease
Human Vaccines & Immunotherapeutics·2018· 59 citedOpen Access
Estimating Typhoid Fever Risk Associated with Lack of Access to Safe Water: A Systematic Literature Review
Journal of Environmental and Public Health·2018· 58 citedOpen Access
Determining the Best Immunization Strategy for Protecting African Children Against Invasive <i>Salmonella</i> Disease
Clinical Infectious Diseases·2018· 20 citedOpen Access
Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial
The Lancet Infectious Diseases·2018· 83 citedOpen Access
Exploring the broader consequences of diarrhoeal diseases on child health
The Lancet Global Health·2018· 29 citedOpen Access
Vaccines against Shigella and enterotoxigenic Escherichia coli : A summary of the 2016 VASE Conference
Vaccine·2017· 32 citedOpen Access
Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa
BMC Infectious Diseases·2017· 7 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

John D. Clemens(24), Stephen J. Savarino(14), Mohammad Ali(12), Malla Rao(12), Robert W. Frenck(8), Ann‐Mari Svennerholm(8), Remon Abu‐Elyazeed(8), Abdollah Naficy(8), Leonard F. Peruski(7), Anna Lena Lopez(6), Shannon D. Putnam(6), Jin Kyung Park(5), Young Ae You(5), Binod Sah(5), Mahesh Puri(5), Jacqueline Deen(5), A. Louis Bourgeois(5), Richard I. Walker(5), Eric R. Hall(5), S. Bassily(5)